Search results
Results From The WOW.Com Content Network
Using marijuana daily for years may raise the overall risk of head and neck cancers three- to five-fold, according to a new study that analyzed millions of medical records. “Our research shows ...
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
Over time, the marijuana gateway hypothesis has been studied more and more. In one published study, the use of marijuana was shown not a reliable gateway cause of illicit drug use. [67] However, social factors and environment influence drug use and abuse, making the gateway effects of cannabis different for those in differing social circumstances.
Regular marijuana use may affect how quickly a person processes things in front of them, according to a study published in the journal JAMA Ophthalmology.
The skin cancer cells self-destructed, the study said. ... The study is a notable addition to a growing body of work suggesting marijuana can do a lot more than get people high. However, there are ...
Marihuana prensada ('pressed marijuana') is a cannabis-derived product widespread among the lower classes of South America, [186] especially from the 90s. Locally it is known as "paraguayo" or "paragua", since its main producer is Paraguay. [187] Marijuana is dried and mixed with binding agents that make it toxic and highly harmful to health. [188]
According to a new NAS report released on Thursday, Marijuana use may raise the risk of developing schizophrenia and other psychoses. Marijuana use linked to schizophrenia, no cancer threat Skip ...
Clinical trials comparing the use of cannabis extracts with Marinol in the treatment of cancer cachexia have demonstrated equal efficacy and well-being among subjects in the two treatment arms. [41] United States federal law currently registers dronabinol as a Schedule III controlled substance , but all other cannabinoids remain Schedule I ...